1. S-1/A: SignPath Pharma, Inc
- Subjects
United States. Securities and Exchange Commission ,United States. Food and Drug Administration ,Business, general ,University of Texas. M.D. Anderson Cancer Center - Abstract
(EDGAR Online via COMTEX) -- signpath.htm -------------------------------------------------------------------------------- -------------------------------------------------------------------------------- As filed with the Securities and Exchange Commission on November 3, 2014 Registration No. 333-198110 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, [...]
- Published
- 2014